When Tocilizumab Became the only Weapon, while the rest of Weapons do not save a Young COVID-19 Patient

Abstract

Background: The world today is suffering from the pandemic of COVID 19, many cases reported in Iraq since 25th of February 2020. Although, majorities were mild symptoms, however, mortality is recorded. Cytokine storm is devastating sequel that could end in death. This study is aimed to report the cytokine storm features and its management.
Case Presentation: An 18 years old male, who lives in Najaf, Iraq, suffered from fever, cough, severe dyspnea, his test was positive for COVID19.During hospitalization, although he was on the recommended therapy, rapidly deteriorated, had hematuria, tachycardia and hypotension with features of Cytokine storm. For the first time in IRAQ, biological drug (ACTEMRAR) was given with dramatic response after failure of other therapies.
Conclusion: COVID19 in IRAQ could affect any age group, regardless the risk factors and immunity state, usual drugs not always could save patients, biological agent should be available as a life saver.